Oxurion NV

As of December 31, 2024, Oxurion NV carries a market capitalization of 919,360.22, placing it among publicly traded companies globally. Its enterprise value stands at 11.79M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Oxurion NV's next confirmed earnings release is scheduled for March 3, 2027.

As of December 31, 2024, Oxurion NV has 3.19M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Oxurion NV maintains a current ratio of 0.22, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Oxurion NV's stock has declined approximately 80.33% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

As of December 31, 2024, Oxurion NV holds 455,000.00 in cash and equivalents against 11.33M in total debt, resulting in a net debt position of 10.74M. Total book value stands at -11.06M, with working capital of -13.04M providing operational flexibility.

Oxurion NV's most recent stock split took place on September 3, 2024.